|
Index of reports
> Cases with Gait Disturbance (28)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Risperdal Consta (Risperidone) where reactions include gait disturbance. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-06
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Tardive Dyskinesia, Extrapyramidal Disorder, Gait Disturbance, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Zyprexa
Indication: Schizophrenia
Possible Risperdal Consta side effects in 54 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-13
Patient: 54 year old female
Reactions: Balance Disorder, Adverse Drug Reaction, Musculoskeletal Stiffness, Unevaluable Event, Gait Disturbance, Thermal Burn, Fall
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Risperdal Consta
Risperdal Consta
Dosage: 50 mg, 1 in 2 wk, intramuscular
Indication: Schizophrenia, Paranoid Type
Risperidone
Dosage: oral
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-07-03
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Disturbance in Attention, Suicide Attempt, Tardive Dyskinesia, Gait Disturbance, Extrapyramidal Disorder, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Zyprexa
Indication: Schizophrenia
Possible Risperdal Consta side effects in 54 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-27
Patient: 54 year old female
Reactions: Adverse Drug Reaction, Thermal Burn, Fall, Hospitalisation, Balance Disorder, Musculoskeletal Stiffness, Unevaluable Event, Gait Disturbance
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Risperdal Consta
Dosage: 50 mg, fortnight
Indication: Schizophrenia, Paranoid Type
Risperidone
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Possible Risperdal Consta side effects in 54 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-27
Patient: 54 year old female
Reactions: Burning Sensation, Balance Disorder, Musculoskeletal Stiffness, Gait Disturbance, Thermal Burn, Feeling Abnormal, Fall
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Indication: Schizophrenia, Paranoid Type
Risperdal Consta
Risperidone
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Other drugs received by patient: Vitamin B-12; Levothyroxine Sodium; Lorazepam; Multi-Vitamin
Possible Risperdal Consta side effects in 54 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-27
Patient: 54 year old female
Reactions: Adverse Drug Reaction, Fall, Thermal Burn, Hospitalisation, Balance Disorder, Musculoskeletal Stiffness, Gait Disturbance, Unevaluable Event
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Risperdal Consta
Dosage: 50 mg, 2/week
Indication: Schizophrenia, Paranoid Type
Risperidone
Dosage: unk df, unk
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Possible Risperdal Consta side effects in male
Reported by a physician from United States on 2012-06-26
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-06-22
Patient: male, weighing 98.9 kg (217.5 pounds)
Reactions: Stereotypy, Musculoskeletal Stiffness, Gait Disturbance, Crying
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Haldol
Indication: Schizoaffective Disorder
Start date: 2012-05-01
End date: 2012-05-01
Haldol
Indication: Schizophrenia
Start date: 2012-05-01
End date: 2012-05-01
Risperdal
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2012-05-05
End date: 2012-06-01
Risperdal
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-05-05
End date: 2012-06-01
Risperdal Consta
Indication: Schizophrenia
Start date: 2012-05-01
Risperdal Consta
Indication: Schizoaffective Disorder
Start date: 2012-05-01
Risperidone
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2012-06-01
Risperidone
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-01
Other drugs received by patient: Lisinopril; Depakote; Depakote
Possible Risperdal Consta side effects in 54 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-19
Patient: 54 year old female
Reactions: Balance Disorder, Adverse Drug Reaction, Musculoskeletal Stiffness, Gait Disturbance, Unevaluable Event, Fall, Thermal Burn
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Risperdal Consta
Dosage: 50 mg, 1 in 2 wk, intramuscular
Indication: Schizophrenia, Paranoid Type
Risperidone
Dosage: oral
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Possible Risperdal Consta side effects in female
Reported by a physician from United Kingdom on 2012-06-12
Patient: female
Reactions: Incorrect Dose Administered, Adverse Drug Reaction, Fall, Thermal Burn, Burning Sensation, Hospitalisation, Balance Disorder, Musculoskeletal Stiffness, Gait Disturbance, Unevaluable Event
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Risperdal Consta
Indication: Schizophrenia, Paranoid Type
Risperidone
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Possible Risperdal Consta side effects in male
Reported by a physician from United States on 2012-06-05
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Injury, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Possible Risperdal Consta side effects in male
Reported by a physician from United States on 2012-05-31
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension
Drug(s) suspected as cause:
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Zyprexa
Indication: Schizophrenia
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-05-15
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension
Drug(s) suspected as cause:
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Possible Risperdal Consta side effects in 52 year old male
Reported by a physician from Switzerland on 2012-05-14
Patient: 52 year old male
Reactions: Haemoglobin Decreased, Weight Decreased, White Blood Cell Count Decreased, Platelet Count Decreased, Gait Disturbance
Drug(s) suspected as cause:
Ethanol
Indication: Product Used FOR Unknown Indication
Risperdal Consta
Indication: Schizophrenia, Catatonic Type
Start date: 2003-01-01
Other drugs received by patient: Actos; Glucovance; Onglyza; Metformin HCL
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-27
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Extrapyramidal Disorder, Gait Disturbance, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Zyprexa
Indication: Schizophrenia
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-05
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Bipolar Disorder
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Schizophrenia, Paranoid Type
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Major Depression
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from United States on 2012-03-23
Patient: male, weighing 95.3 kg (209.6 pounds)
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Bipolar Disorder
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Major Depression
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Schizophrenia, Paranoid Type
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: ndc 050468-306
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Possible Risperdal Consta side effects in 41 year old female
Reported by a physician from Germany on 2012-03-14
Patient: 41 year old female
Reactions: Back Pain, Ear Discomfort, Tinnitus, Nausea, Pain in Extremity, Headache, Gastric Disorder, Sleep Disorder, Gait Disturbance, Inflammation
Drug(s) suspected as cause:
Risperdal Consta
Indication: Product Used FOR Unknown Indication
Start date: 2005-01-01
End date: 2011-05-01
Risperdal Consta
Start date: 2011-05-01
End date: 2011-10-01
Possible Risperdal Consta side effects in male
Reported by a consumer/non-health professional from Brazil on 2012-03-05
Patient: male
Reactions: Confusional State, Vomiting, Pneumonia, Condition Aggravated, Gait Disturbance, Convulsion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Possible Risperdal Consta side effects in female
Reported by a consumer/non-health professional from Japan on 2012-03-02
Patient: female
Reactions: Gait Disturbance, Depression, Aggression
Drug(s) suspected as cause:
Risperdal Consta
Possible Risperdal Consta side effects in female
Reported by a physician from United Kingdom on 2012-02-22
Patient: female
Reactions: Balance Disorder, Musculoskeletal Stiffness, Gait Disturbance, Unevaluable Event, Fall, Thermal Burn
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Risperdal Consta
Possible Risperdal Consta side effects in 43 year old female
Reported by a physician from Japan on 2012-02-07
Patient: 43 year old female
Reactions: Incorrect Route of Drug Administration, Inappropriate Schedule of Drug Administration, Multi-Organ Failure, Dehydration, Gait Disturbance, Neuroleptic Malignant Syndrome, Urinary Retention, Decreased Appetite, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Other drugs received by patient: Levotomin; Clonazepam; Amoban
Possible Risperdal Consta side effects in female
Reported by a physician from United Kingdom on 2012-02-07
Patient: female
Reactions: Balance Disorder, Musculoskeletal Stiffness, Unevaluable Event, Gait Disturbance, Fall, Thermal Burn
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Risperdal Consta
Possible Risperdal Consta side effects in female
Reported by a physician from United Kingdom on 2012-01-25
Patient: female
Reactions: Balance Disorder, Musculoskeletal Stiffness, Unevaluable Event, Gait Disturbance, Thermal Burn, Fall
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Risperdal Consta
Possible Risperdal Consta side effects in female
Reported by a consumer/non-health professional from United States on 2012-01-25
Patient: female, weighing 74.8 kg (164.6 pounds)
Reactions: Agitation, Drug Ineffective, Restlessness, Dyskinesia, Hyperhidrosis, Constipation, Myalgia, Speech Disorder, Overdose, Incontinence, Insomnia, Sedation, Skin Odour Abnormal, Musculoskeletal Stiffness, Gait Disturbance
Drug(s) suspected as cause:
Invega Sustenna
Indication: Schizophrenia
Start date: 2012-01-18
Risperdal
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-12-18
End date: 2012-01-19
Risperdal Consta
Indication: Schizophrenia
Start date: 2011-12-18
End date: 2011-12-30
Possible Risperdal Consta side effects in female
Reported by a consumer/non-health professional from United Kingdom on 2012-01-18
Patient: female
Reactions: Balance Disorder, Musculoskeletal Stiffness, Unevaluable Event, Gait Disturbance, Fall
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Risperdal Consta
Possible Risperdal Consta side effects in 41 year old
Reported by a consumer/non-health professional from Germany on 2011-11-23
Patient: 41 year old
Reactions: Back Pain, Ear Discomfort, Tinnitus, Nausea, Pain in Extremity, Headache, Gastric Disorder, Sleep Disorder, Gait Disturbance, Inflammation
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2011-05-01
End date: 2011-10-01
Risperdal Consta
Indication: Product Used FOR Unknown Indication
Start date: 2005-01-01
End date: 2011-05-01
Possible Risperdal Consta side effects in female
Reported by a consumer/non-health professional from United States on 2011-10-24
Patient: female, weighing 63.5 kg (139.7 pounds)
Reactions: Loss of Control of Legs, Muscular Weakness, Schizophrenia, Cerebrovascular Accident, Joint Stiffness, Arthropathy, Arthralgia, Heart Rate Increased, Vision Blurred, Gait Disturbance, Arthritis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Indication: Schizophrenia
Start date: 2009-12-01
End date: 2011-07-29
Risperidone
Administration route: Oral
Indication: Schizophrenia
Start date: 2001-01-01
|
